These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 16091499

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Analysis of RET polymorphisms and haplotypes in the context of sporadic medullary thyroid carcinoma.
    Fernández RM, Peciña A, Antiñolo G, Navarro E, Borrego S.
    Thyroid; 2006 Apr; 16(4):411-7. PubMed ID: 16646689
    [Abstract] [Full Text] [Related]

  • 3. Association study of 69 genes in the ret pathway identifies low-penetrance loci in sporadic medullary thyroid carcinoma.
    Ruiz-Llorente S, Montero-Conde C, Milne RL, Moya CM, Cebrián A, Letón R, Cascón A, Mercadillo F, Landa I, Borrego S, Pérez de Nanclares G, Alvarez-Escolá C, Díaz-Pérez JA, Carracedo A, Urioste M, González-Neira A, Benítez J, Santisteban P, Dopazo J, Ponder BA, Robledo M, Medullary Thyroid Carcinoma Clinical Group.
    Cancer Res; 2007 Oct 01; 67(19):9561-7. PubMed ID: 17909067
    [Abstract] [Full Text] [Related]

  • 4. Medullary thyroid carcinoma (MTC) and RET proto-oncogene: mutation spectrum in the familial cases and a meta-analysis of studies on the sporadic form.
    Figlioli G, Landi S, Romei C, Elisei R, Gemignani F.
    Mutat Res; 2013 Oct 01; 752(1):36-44. PubMed ID: 23059849
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [RET and GFRA1 germline polymorphisms in medullary thyroid cancer patients].
    Severskaia NV, Saenko VA, Il'in AA, Chebotareva IV, Rumiantsev PO, Isaev PA, Medvedev VS, Iasmita S.
    Mol Biol (Mosk); 2006 Oct 01; 40(3):425-35. PubMed ID: 16813162
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. RET genotypes in sporadic medullary thyroid cancer: studies in a large Italian series.
    Fugazzola L, Muzza M, Mian C, Cordella D, Barollo S, Alberti L, Cirello V, Dazzi D, Girelli ME, Opocher G, Beck-Peccoz P, Persani L.
    Clin Endocrinol (Oxf); 2008 Sep 01; 69(3):418-25. PubMed ID: 18284634
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Evaluation of germline sequence variants of GFRA1, GFRA2, and GFRA3 genes in a cohort of Spanish patients with sporadic medullary thyroid cancer.
    Borrego S, Fernández RM, Dziema H, Japón MA, Marcos I, Eng C, Antiñolo G.
    Thyroid; 2002 Nov 01; 12(11):1017-22. PubMed ID: 12490080
    [Abstract] [Full Text] [Related]

  • 12. [Genetic polymorphisms: implications in the pathogenesis of medullary thyroid carcinoma].
    Rocha AP, Magalhães PK, Maia AL, Maciel LM.
    Arq Bras Endocrinol Metabol; 2007 Jul 01; 51(5):723-30. PubMed ID: 17891235
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. RET genetic screening in patients with medullary thyroid cancer and their relatives: experience with 807 individuals at one center.
    Elisei R, Romei C, Cosci B, Agate L, Bottici V, Molinaro E, Sculli M, Miccoli P, Basolo F, Grasso L, Pacini F, Pinchera A.
    J Clin Endocrinol Metab; 2007 Dec 01; 92(12):4725-9. PubMed ID: 17895320
    [Abstract] [Full Text] [Related]

  • 15. Intronic single nucleotide polymorphisms in the RET protooncogene are associated with a subset of apparently sporadic pheochromocytoma and may modulate age of onset.
    McWhinney SR, Boru G, Binkley PK, Peczkowska M, Januszewicz AA, Neumann HP, Eng C.
    J Clin Endocrinol Metab; 2003 Oct 01; 88(10):4911-6. PubMed ID: 14557473
    [Abstract] [Full Text] [Related]

  • 16. The influence of gender, age, and RET polymorphisms on C-cell hyperplasia and medullary thyroid carcinoma.
    Weinhaeusel A, Scheuba C, Lauss M, Kriegner A, Kaserer K, Vierlinger K, Haas OA, Niederle B.
    Thyroid; 2008 Dec 01; 18(12):1269-76. PubMed ID: 18976163
    [Abstract] [Full Text] [Related]

  • 17. Occurrence of the Cys611Tyr mutation and a novel Arg886Trp substitution in the RET proto-oncogene in multiple endocrine neoplasia type 2 families and sporadic medullary thyroid carcinoma cases originating from the central region of Portugal.
    Prazeres HJ, Rodrigues F, Figueiredo P, Naidenov P, Soares P, Bugalho MJ, Lacerda M, Campos B, Martins TC.
    Clin Endocrinol (Oxf); 2006 Jun 01; 64(6):659-66. PubMed ID: 16712668
    [Abstract] [Full Text] [Related]

  • 18. Nationwide French Study of RET Variants Detected from 2003 to 2013 Suggests a Possible Influence of Polymorphisms as Modifiers.
    Lebeault M, Pinson S, Guillaud-Bataille M, Gimenez-Roqueplo AP, Carrie A, Barbu V, Pigny P, Bezieau S, Rey JM, Delvincourt C, Giraud S, Veyrat-Durebex C, Saulnier P, Bouzamondo N, Chabbert M, Blin J, Mohamed A, Romanet P, Borson-Chazot F, Rohmer V, Barlier A, Mirebeau-Prunier D.
    Thyroid; 2017 Dec 01; 27(12):1511-1522. PubMed ID: 28946813
    [Abstract] [Full Text] [Related]

  • 19. RET exon 11 (G691S) polymorphism is significantly more frequent in sporadic medullary thyroid carcinoma than in the general population.
    Elisei R, Cosci B, Romei C, Bottici V, Sculli M, Lari R, Barale R, Pacini F, Pinchera A.
    J Clin Endocrinol Metab; 2004 Jul 01; 89(7):3579-84. PubMed ID: 15240649
    [Abstract] [Full Text] [Related]

  • 20. RET genetic screening in patients with medullary thyroid cancer: the Moroccan experience.
    Abdelhakim A, Barlier A, Kebbou M, Benabdeljalil N, Timinouni M, Taoufiq F, Roche C, El Antri S.
    J Cancer Res Ther; 2009 Jul 01; 5(3):198-202. PubMed ID: 19841562
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.